Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-26 6:22 pm Purchase |
2025-03-24 | 13G | Scinai Immunotherapeutics Ltd. SCNI |
YA II PN, Ltd. | 93,274 9.900% |
93,274 (New Position) |
Filing History |
| 2025-03-04 9:58 pm Unchanged |
2025-02-09 | 13G | Scinai Immunotherapeutics Ltd. SCNI |
LCK JNK 1 LLC | 80,757 9.500% |
0 (Unchanged) |
Filing History |
| 2025-02-24 06:04 am Purchase |
2025-02-09 | 13G | Scinai Immunotherapeutics Ltd. SCNI |
LCK JNK 1 LLC | 80,757 9.500% |
80,757 (New Position) |
Filing History |
| 2025-01-24 9:21 pm Purchase |
2024-12-31 | 13G | Scinai Immunotherapeutics Ltd. SCNI |
Stone Daniel E. | 87,746 9.990% |
25,346 (+40.62%) |
Filing History |
| 2025-01-03 6:16 pm Sale |
2024-12-31 | 13G | BiondVax Pharmaceuticals Ltd. BVXV |
SABBY MANAGEMENT LLC | 29,051 4.900% |
-191,612 (-86.83%) |
Filing History |
| 2024-11-14 4:28 pm Purchase |
2024-09-30 | 13G | Scinai Immunotherapeutics Ltd. SCNI |
Armistice Capital, LLC | 44,800 4.990% |
44,800 (New Position) |
Filing History |
| 2024-08-20 3:06 pm Purchase |
2024-08-19 | 13G | Scinai Immunotherapeutics Ltd. SCNI |
Stone Daniel E. | 62,400 7.400% |
62,400 (New Position) |
Filing History |
| 2024-03-12 4:17 pm Unchanged |
2024-03-12 | 13D | Scinai Immunotherapeutics Ltd. SCNI |
Stone Daniel E. | 62,400 12.960% |
0 (Unchanged) |
Filing History |
| 2024-02-14 3:53 pm Purchase |
2023-12-31 | 13G | Scinai Immunotherapeutics Ltd. SCNI |
Armistice Capital, LLC | 51,832 9.990% |
51,832 (New Position) |
Filing History |
| 2024-01-24 2:33 pm Purchase |
2023-12-31 | 13G | Scinai Immunotherapeutics Ltd. SCNI |
Stone Daniel E. | 62,400 12.960% |
32,585 (+109.29%) |
Filing History |
| 2024-01-02 4:54 pm Sale |
2023-12-31 | 13G | BiondVax Pharmaceuticals Ltd. BVXV |
SABBY MANAGEMENT LLC | 220,663 11.000% |
-7,666 (-3.36%) |
Filing History |
| 2023-02-06 2:08 pm Purchase |
2022-12-31 | 13G | Scinai Immunotherapeutics Ltd. SCNI |
Stone Daniel E. | 29,815 8.400% |
29,815 (New Position) |
Filing History |
| 2023-01-04 09:21 am Purchase |
2022-12-31 | 13G | BiondVax Pharmaceuticals Ltd. BVXV |
SABBY MANAGEMENT LLC | 228,329 11.000% |
228,329 (New Position) |
Filing History |
| 2022-12-27 09:04 am Purchase |
2022-12-20 | 13D | BiondVax Pharmaceuticals Ltd. BVXV |
NACHT MARIUS | 170,961,770 12.300% |
153,865,593 (+900.00%) |
Filing History |
| 2022-10-06 10:23 am Purchase |
2022-09-19 | 13G | BiondVax Pharmaceuticals Ltd. BVXV |
Stone Daniel E. | 3,748,852 5.020% |
3,748,852 (New Position) |
Filing History |
| 2022-01-11 12:47 pm Unchanged |
2021-12-29 | 13D | BiondVax Pharmaceuticals Ltd. BVXV |
NACHT MARIUS | 17,096,177 23.600% |
0 (Unchanged) |
Filing History |
| 2021-02-09 06:01 am Purchase |
2021-02-02 | 13D | BiondVax Pharmaceuticals Ltd. BVXV |
NACHT MARIUS | 17,096,177 30.600% |
11,720,094 (+218.00%) |
Filing History |